SPHK2 and metabolic dysfunction-associated steatotic liver disease: In the following work, we mainly focused on analyzing the differences in non-tumorous liver tissues of WT and Sphk2-KO mice in order to understand why Sphk2-KO suppressed NAFLD-HCC.